Merck’s $10.8B Prometheus buyout, GSK’s $2B Bellus takeover fuel M&A buzz; CAR-T data leak; Best of #AACR23; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
We’re getting ready to dive into Q1 earnings next week from some of the biggest pharma players. There are also several key FDA decisions on our watch list. Stay tuned for the most up-to-date coverage.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 170,200+ biopharma pros reading Endpoints daily — and it's free.